ロード中...
Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.
Fourteen consecutive patients with chronic inflammatory rheumatic disease and reactive renal amyloidosis were treated with alkylating cytostatics in 22 separate periods varying in duration between six and 30 months. Chlorambucil alone was given in 14 treatment periods, cyclophosphamide alone in six,...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1987
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1003383/ https://ncbi.nlm.nih.gov/pubmed/3500678 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|